Diagnosis of Certain Types of Cancer: Such as soft tissue sarcoma and mast cell leukemia. Assessment of Treatment Response: Expression of the c-kit gene can affect the effectiveness of targeted therapies. Identification of Genetic Alterations: Which may be associated with disease progression or resistance to treatment. Guiding Treatment Options: Based on test results, it can be determined whether targeted therapy, such as Imatinib (Gleevec), is suitable for the patient.

Sarcoma Patients: Such as soft tissue sarcoma, used to determine c-kit gene expression. Patients with Mast Cell Leukemia: To assist in diagnosis and monitoring of the condition. Individuals with a Family History of c-kit Related Cancers: To assess risk. Patients Receiving Targeted Therapies: To determine the effectiveness of treatments such as Imatinib. Individuals Showing Unusual Symptoms: Such as unexplained lumps or pain in soft tissues.

Presence of Unexplained Lumps or Tumors: Such as tumors in soft tissues or under the skin. Persistent or Unexplained Pain: In certain areas of the body that may indicate the presence of a tumor. Changes in Weight: Unexplained weight loss or sudden weight gain. Family History of Tumors: Especially tumors associated with c-kit expression. Symptoms Related to Leukemia: Such as extreme fatigue, unexplained bleeding, or easy bruising.

What is the purpose of this test? It aims to determine the presence and expression of the c-kit gene, which helps in diagnosing and monitoring certain types of cancer. How is the sample collected? A tissue sample from the tumor or a blood sample is collected, as needed. Are there any special preparations before the test? Usually, no special preparations are required, but consulting a physician is recommended. How long does it take to get results? Results are typically available within several days to a week, depending on the laboratory. How are the results interpreted? Results are interpreted by a physician based on c-kit gene expression levels and compared to normal ranges. Are there any risks associated with this test? Risks are generally low, but may be related to the biopsy or blood draw procedure.

c-kit Expression: Expression of the c-kit gene is expected to be absent or low in healthy tissues. Positive Results: Elevated expression levels may indicate the presence of tumors such as soft tissue sarcoma or mast cell leukemia.

c-Kit (CD117) Gene Test | Lahalak Platform

Advanced test to detect c-Kit (CD117) gene expression, assisting in early diagnosis of specific tumors and determining the most effective treatment protocol.

Prices starts from: 3458.61 SAR

Scientific name: c-Kit (CD117) Gene Expression Test

The c-kit analysis is a laboratory test used to determine the presence and expression of the c-kit gene (also known as CD117) in cells. This gene is considered one of the vital genes that plays an important role in cell growth and development, and it is particularly expressed in some types of cancer cells. This analysis is mainly used in the diagno...

c-Kit (CD117) Gene Expression Test - c-Kit Gene Expression Screening

Service type Laboratory Genetic Test

Duration 15-20 minutes

Fasting Fasting is not required

Prices Starting from 3458.61 SAR

Included Services

C-Kit Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Diagnosis of Certain Types of Cancer: Such as soft tissue sarcoma and mast cell leukemia.
Assessment of Treatment Response: Expression of the c-kit gene can affect the effectiveness of targeted therapies.
Identification of Genetic Alterations: Which may be associated with disease progression or resistance to treatment.
Guiding Treatment Options: Based on test results, it can be determined whether targeted therapy, such as Imatinib (Gleevec), is suitable for the patient.

Recommended groups

Sarcoma Patients: Such as soft tissue sarcoma, used to determine c-kit gene expression.
Patients with Mast Cell Leukemia: To assist in diagnosis and monitoring of the condition.
Individuals with a Family History of c-kit Related Cancers: To assess risk.
Patients Receiving Targeted Therapies: To determine the effectiveness of treatments such as Imatinib.
Individuals Showing Unusual Symptoms: Such as unexplained lumps or pain in soft tissues.

Symptoms indicative

Presence of Unexplained Lumps or Tumors: Such as tumors in soft tissues or under the skin.
Persistent or Unexplained Pain: In certain areas of the body that may indicate the presence of a tumor.
Changes in Weight: Unexplained weight loss or sudden weight gain.
Family History of Tumors: Especially tumors associated with c-kit expression.
Symptoms Related to Leukemia: Such as extreme fatigue, unexplained bleeding, or easy bruising.

FAQs

What is the purpose of this test? It aims to determine the presence and expression of the c-kit gene, which helps in diagnosing and monitoring certain types of cancer.
How is the sample collected? A tissue sample from the tumor or a blood sample is collected, as needed.
Are there any special preparations before the test? Usually, no special preparations are required, but consulting a physician is recommended.
How long does it take to get results? Results are typically available within several days to a week, depending on the laboratory.
How are the results interpreted? Results are interpreted by a physician based on c-kit gene expression levels and compared to normal ranges.
Are there any risks associated with this test? Risks are generally low, but may be related to the biopsy or blood draw procedure.

Normal Levels

c-kit Expression: Expression of the c-kit gene is expected to be absent or low in healthy tissues.
Positive Results: Elevated expression levels may indicate the presence of tumors such as soft tissue sarcoma or mast cell leukemia.